REGISTER LOG IN CORPORATE About NanoString Careers News Contact Us Company Investors Life Sciences Prosigna™ Home | Investor Relations | Press Releases Request Info RSS Print Investor Relations Company Profile Press Releases Events & Webcasts Corporate Governance Financial Information Stock Information Analyst Coverage Investor FAQs Contact Us Stock Quote (NASDAQ: NSTG) Price: 19.74 Change: - 0.24 Day High: 19.99 Day Low: 19.23 Volume: 186,908 4:00 PM ET on Oct 03, 2016 Delayed at least 20 minutes. Provided by eSignal. Shareholder Tools Shareholder Briefcase Email Alerts Download Library Snapshot RSS News Feeds Search Investor Relations Press Releases Year: All Years 2016 2015 2014 2013 2012 2011 2010 2009 All Releases PRESS RELEASESep 13, 2016 NanoString Technologies Appoints Kirk Malloy, Ph.D. to Board of Directors read more PRESS RELEASEAug 25, 2016 NanoString Technologies to Present at Two Upcoming Healthcare Conferences read more PRESS RELEASEAug 03, 2016 NanoString Technologies Releases Operating Results for Second Quarter of 2016 read more PRESS RELEASEJul 07, 2016 NanoString Technologies to Release Second Quarter 2016 Financial Results and Host Conference Call on Wednesday, August 3, 2016 read more PRESS RELEASEJun 02, 2016 NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) read more PRESS RELEASEMay 26, 2016 Cigna Issues Positive Coverage Decision for NanoString's Prosigna® Breast Cancer Assay read more PRESS RELEASEMay 24, 2016 NanoString Technologies to Present at the Jefferies 2016 Healthcare Conference read more PRESS RELEASEMay 09, 2016 Aetna Issues Positive Coverage Decision for NanoString's Prosigna® Breast Cancer Assay read more PRESS RELEASEMay 05, 2016 NanoString Technologies Releases Operating Results for First Quarter of 2016 read more PRESS RELEASEApr 27, 2016 NanoString Technologies to Present at the Bank of America Merrill Lynch 2016 Health Care Conference read more PRESS RELEASEApr 18, 2016 NanoString Technologies Presents Proof-of-Concept Data for Multiplexed Digital IHC in Tumor Tissues at AACR Meeting read more PRESS RELEASEApr 14, 2016 NanoString Technologies Unveils New nCounter Vantage™ Assays to Power Cancer Research With 3D Biology™ read more PRESS RELEASEApr 13, 2016 NanoString Technologies to Release First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 5, 2016 read more PRESS RELEASEApr 11, 2016 NanoString Technologies and HalioDx Enter Into Collaboration Agreement to Jointly Develop and Commercialize Novel Gene Expression Assays in Immuno-oncology read more PRESS RELEASEMar 21, 2016 NanoString Technologies Receives Favorable Final Local Coverage Determination by Noridian Healthcare Solutions for Its Prosigna Breast Cancer Assay read more PRESS RELEASEMar 10, 2016 NanoString Technologies and Cell Signaling Technology Announce Agreement to Expand Suite of 3D Biology Assays read more PRESS RELEASEFeb 29, 2016 NanoString Technologies Releases Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Outlook read more PRESS RELEASEFeb 29, 2016 NanoString Technologies and Merck Expand Collaboration to Develop and Commercialize Novel Diagnostic Test to Predict Response to KEYTRUDA® (pembrolizumab) read more PRESS RELEASEFeb 22, 2016 NanoString Technologies to Present at the Cowen and Company 36th Annual Health Care Conference read more PRESS RELEASEFeb 12, 2016 NanoString Technologies to Release Fourth Quarter 2015 Financial Results and Host Conference Call on Monday, February 29, 2016 read more Showing 1-20 of 163 Page: 1 2 3 4 5 ... 9 Next 20 CORPORATE Company Overview Management Team Press / Media Request Information Location / Contact Distributors - LS Careers Legal Privacy Policy Cookies Policy LIFE SCIENCES Life Sciences Home nCounter® Technology nCounter® Dx System nCounter® Products nCounter Elements™ GPRs Applications Overview nCounter Publications Request Information Order Information Contact Support nDesign™ Gateway PROSIGNA™ Prosigna Home Contact Us Contact Us NanoString Technologies, Inc. 530 Fairview Ave N Seattle, WA 98109 Tel: 1 888 358 6266 Fax: 1 206 378 6288 Email: info@nanostring.com SUBSCRIBE TO NEWSLETTER Follow Us Follow @nanostringtech © 2016 NanoString® Technologies, Inc. All rights reserved. Corporate Overview Investors Life Sciences Prosigna™ Legal Privacy Policy Cookies Policy 1 888 358 6266